Multiple Sclerosis
Cardiovascular-kidney-metabolic syndrome rose in US over 20 years
BOSTON — The prevalence of cardiovascular-kidney-metabolic syndrome has increased during the past 20 years among U.S. adults, with a drop in the number of adults with no risk factors, data show.
Long-acting diuretic chlorthalidone may increase kidney stone risk
BOSTON — Long-acting diuretic chlorthalidone may increase the risk for kidney stones in adults who have previously had them, according to findings presented at the National Kidney Foundation Spring Clinical Meetings.
Stem cell transplant suppresses relapse in multiple sclerosis up to 4 years
SAN DIEGO — Among individuals from the United Kingdom with multiple sclerosis, autologous hematopoietic stem cell transplantation led to significant relapse suppression up to 4 years, according to a speaker.
CMS rules may limit patient choices for kidney care
LAS VEGAS — The CMS End-Stage Renal Disease Treatment Choices model was designed to offer optimal care while cutting Medicare expenses, but policy may not always have the intended effect, according to a speaker.
Understanding brain-immune interaction key to developing multiple sclerosis therapies
WEST PALM BEACH, Fla. — More than a century of scientific research has shed light on the neuroimmune interaction in multiple sclerosis, which will be key for the development of disease-specific therapies, according to Jack P. Antel, MD.
Telehealth clinic reduces distress among people with graft-versus-host disease
A multidisciplinary, virtual platform showed preliminary feasibility for reducing distress and improving access for patients with graft-versus-host disease, according to findings published in Transplantation and Cellular Therapy.
Large language model may improve diagnosis of multiple sclerosis
WEST PALM BEACH, Fla. — Large language model algorithms may be reliable for synthesizing large patient databases to more rapidly and accurately diagnose multiple sclerosis, according to a poster presented at ACTRIMS.
Fampridine may have positive impact for optic neuritis in multiple sclerosis
WEST PALM BEACH, Fla. — Treatment with fampridine may positively impact patients with multiple sclerosis who are recovering from optic neuritis, but more extensive clinical trials are required to fully assess its effectiveness, according to a poster at ACTRIMS.
Women oncologists receive significantly lower general payments from industry than men
An analysis of industry payments to medical oncologists showed men received significantly higher speaker fees, consulting fees and other general payments than women between 2016 and 2020.
AI helps identify psychiatric comorbidities in multiple sclerosis
WEST PALM BEACH, Fla. — A machine learning model using existing clinical data may help clinicians screen for comorbid anxiety and depression in patients with multiple sclerosis, according to a poster presented at ACTRIMS.